Regulatory burdens have raised the capital requirements for early-stage companies, causing many to do what would have been ...

The firm reported Wednesday that its third quarter Diagnostics revenues declined nearly 7 percent year over year.

An explosion in Medicare spending on epilepsy testing resembles a pattern of improper payments for genetic testing that was ...

Researchers hope to soon commercialize a simple, inexpensive, and accessible screening test that uses taste as a detection tool for presymptomatic flu infections.

Last week, readers were most interested in a story about Meridian Bioscience's two-pronged approach to fuel its success.

The test is intended for patients ages 55 and older presenting with signs, symptoms, or complaints of cognitive decline.

Saliva, sweat, and interstitial fluid have shown promise as alternative sample types in situations where blood may be too hard to access.

The firm is leading a collaborative project on the development of a test to detect markers of 36 types of cancer in breath and urine samples.

NEW YORK – Bolstered by recent study results, cancer diagnostics firm SeekIn is developing a low-cost lung cancer blood test with hopes of making screening more widely available, including in low- and ...

NEW YORK – Hemex Health and Terumo Blood and Cell Technologies have partnered to expand access to rapid and affordable Hb variant testing to detect sickle cell disease. The firms will collaborate on ...